Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_provenance.
- NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_assertion description "[We investigated dopaminergic inhibition of CD4+CD25(high) regulatory T lymphocytes (Treg) in relapsing-remitting multiple sclerosis (MS) patients treated with interferon (IFN)-?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_provenance.
- NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_assertion evidence source_evidence_literature NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_provenance.
- NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_assertion SIO_000772 22472872 NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_provenance.
- NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_assertion wasDerivedFrom befree-20140225 NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_provenance.
- NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_assertion wasGeneratedBy ECO_0000203 NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_provenance.